Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Montebello, Oslo, Norway.
Traffic. 2011 Sep;12(9):1211-26. doi: 10.1111/j.1600-0854.2011.01220.x. Epub 2011 Jun 13.
Ligand-mediated lysosomal degradation of growth factor receptors, mediated by the endosomal sorting complex required for transport (ESCRT) machinery, is a mechanism that attenuates the cellular response to growth factors. In this article, we present a novel regulatory mechanism that involves ligand-mediated degradation of a key component of the sorting machinery itself. We have investigated the endosomal localization of subunits of the four ESCRTs-Hrs (ESCRT-0), Tsg101 (ESCRT-I), EAP30/Vps22 (ESCRT-II) and charged multivesicular body protein 3/Vps24 (ESCRT-III). All the components were detected on the limiting membrane of multivesicular endosomes (MVEs). Surprisingly, however, Tsg101 and other ESCRT-I subunits were also detected within intraluminal vesicles (ILVs) of MVEs. Tsg101 was sequestered along with cargo during endosomal sorting into ILVs and further degraded in lysosomes. Importantly, ESCRT-mediated downregulation of two distinct cargoes, epidermal growth factor receptor (EGFR) and connexin43, mutually made cells refractory to degradation of the other cargo. Our observations indicate that the degradation of a key ESCRT component along with cargo represents a novel feedback control of endosomal sorting by preventing collateral degradation of cell surface receptors following stimulation of one specific pathway.
配体介导的生长因子受体溶酶体降解,由内体分选复合物必需运输(ESCRT)机制介导,是一种减弱细胞对生长因子反应的机制。在本文中,我们提出了一种新的调节机制,涉及配体介导的分选机制本身的关键组成部分的降解。我们研究了四个 ESCRTs-Hrs(ESCRT-0)、Tsg101(ESCRT-I)、EAP30/Vps22(ESCRT-II)和带电荷的多泡体蛋白 3/Vps24(ESCRT-III)亚基的内体定位。所有成分都在多泡体末端(MVEs)的限制膜上被检测到。然而,令人惊讶的是,Tsg101 和其他 ESCRT-I 亚基也在 MVEs 的腔内小泡(ILVs)中被检测到。Tsg101 与货物一起在分选到腔内小泡的过程中被隔离,并在溶酶体中进一步降解。重要的是,ESCRT 介导的两种不同货物(表皮生长因子受体(EGFR)和连接蛋白 43)的下调使细胞对另一种货物的降解产生抗性。我们的观察表明,与货物一起降解关键的 ESCRT 成分代表了内体分选的一种新的反馈控制,防止了一种特定途径刺激后细胞表面受体的附带降解。